Expression of endoglin in human melanocytic lesions

Clinical and Experimental Dermatology

Volumn 27, Issue 2, 2002, Pages 153-156

  Dawn, G ^a,b   MacKie, R M ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b WESTERN INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOGLIN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; JUVENILE MELANOMA; MALE; MELANOCYTE; MELANOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE SECTION; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; FEMALE; HUMANS; MALE; MELANOCYTES; MELANOMA; MIDDLE AGED; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; NEVUS, PIGMENTED; RECEPTORS, CELL SURFACE; SKIN NEOPLASMS; STAINING AND LABELING; SURVIVAL ANALYSIS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0036037376     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2230.2002.00976.x     Document Type: Article

References (5)

1. Up-regulation of endoglin on vascular endothelial cells in human solid tumors: Implications for diagnosis and therapy
2. CD 105 and angiogenesis
3. Angiogenesis in cancer, vascular, rheumatoid, and other disease
4. Expression and structural features of endoglin (CD105), a transforming growth factor β1 and β3 binding protein, in human melanoma
5. Immunocyto-chemical detection of endoglin is indicative of angiogenesis in malignant melanoma